Ascentage Pharma Group International (AAPG)vsRevolution Medicines Inc (RVMD)
AAPG
Ascentage Pharma Group International
$21.66
+0.74%
HEALTHCARE · Cap: $2.01B
RVMD
Revolution Medicines Inc
$144.15
+1.65%
HEALTHCARE · Cap: $30.65B
Smart Verdict
WallStSmart Research — data-driven comparison
Ascentage Pharma Group International generates 77275% more annual revenue ($574.12M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -216.5%. AAPG earns a higher WallStSmart Score of 29/100 (F).
AAPG
Avoid29
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+6.8%
Fair Value
$26.39
Current Price
$21.66
$4.73 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 117.0% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
Trading at 10.4x book value
0.0% earnings growth
Weak financial health signals
ROE of -154.6% — below average capital efficiency
Trading at 17.4x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : AAPG
The strongest argument for AAPG centers on Revenue Growth. Revenue growth of 117.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Altman Z-Score.
Bear Case : AAPG
The primary concerns for AAPG are Price/Book, EPS Growth, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
AAPG profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
AAPG is growing revenue faster at 117.0% — sustainability is the question.
RVMD generates stronger free cash flow (-356M), providing more financial flexibility.
Bottom Line
AAPG scores higher overall (29/100 vs 24/100) and 117.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ascentage Pharma Group International
HEALTHCARE · BIOTECHNOLOGY · USA
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company is headquartered in Suzhou, China.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?